KELLY CRENSHAW: Open Payments
NPI 1790161263 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$765 in 37 payments from 14 companies in 2025. Trend: 2023 $1,121 · 2024 $347 · 2025 $765
Food & beverage: $765
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 6 | $112 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $98 |
| ABBVIE INC. | 4 | $72 |
| Neurocrine BioSciences, Inc. | 3 | $68 |
| Collegium Pharmaceutical, Inc. | 3 | $64 |
| E.R. Squibb & Sons, L.L.C. | 3 | $64 |
| Janssen Pharmaceuticals, Inc | 3 | $60 |
| Lundbeck LLC | 2 | $52 |
| Tris Pharma Inc | 3 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
Products named: CAPLYTA, REXULTI, VRAYLAR, INGREZZA, Jornay PM, COBENFY, SPRAVATO, Auvelity.
Industry payments across NC — which companies pay providers there.
